A Appraisal of Novartis (Bangladesh) Limited

dc.contributor.author	Chowdhury, Faiyaaz Mohammad
dc.date.accessioned	2014-11-21T11:24:12Z
dc.date.available	2014-11-21T11:24:12Z
dc.date.issued	8/16/2010
dc.identifier.uri	http://dspace.ewubd.edu/handle/2525/1014
dc.description	This thesis submitted in partial fulfillment of the requirements for the degree of Bachelor in Business Administration of East West University, Dhaka, Bangladesh.	en_US
dc.description.abstract	Novartis International AG is a multinational pharmaceutical company based in Basel, Switzerland, ranking number one in revenues, which accounted over $53 billion in 2008, and number three in sales, which accounted 36.172 billon in 2008. Novartis is one of the largest healthcare companies in the world and a leading giant among pharmaceutical companies. Novartis produces medications for many diseases, cancer and cardiovascular medications that make up the bulk of sales. These medications include blockbuster drugs Gleevec and Diovan, which will benefit people who are more susceptible to cancer or cardiovascular problems. In addition to their current drugs, Novartis has one of the strongest pipelines in the pharmaceutical industry, with over 50 new products set to premier in the next several years.	en_US
dc.language.iso	en_US	en_US
dc.publisher	East West University	en_US
dc.relation.ispartofseries	;BBA00221
dc.subject	Appraisal of Novartis Bangladesh Ltd.	en_US
dc.title	A Appraisal of Novartis (Bangladesh) Limited	en_US
dc.type	Thesis	en_US